Keloid treatment: what about adjuvant radiotherapy?

References

• Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am. 1997;77(3):701–730. doi:10.1016/S0039-6109(05)70576-49194888
   PubMed Web of Science ®Google Scholar
• Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg. 1989;84(5):827–837. doi:10.1097/00006534-198911000-000212682703
   PubMed Web of Science ®Google Scholar
• Marneros AG, Norris JE, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol. 2001;137:1429–1434.11708945
   PubMedGoogle Scholar
• Abergel RP, Pizzurro D, Meeker CA, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol. 1985;84(5):384–390. doi:10.1111/1523-1747.ep122654713998489
   PubMed Web of Science ®Google Scholar
• Bettinger DA, Yager DR, Diegelmann RF, Cohen IK. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg. 1996;98(5):827–833. doi:10.1097/00006534-199610000-000128823022
   PubMed Web of Science ®Google Scholar
• Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg. 2001;107(1):87–96. doi:10.1097/00006534-200101000-0001411176606
   PubMed Web of Science ®Google Scholar
• Akasaka Y, Fujita K, Ishikawa Y, et al. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen. 2001;9:501–506. doi:10.1046/j.1524-475x.2001.00501.x11896992
   PubMed Web of Science ®Google Scholar
• Younai S, Nichter LS, Wellisz T, et al. Modulation of collagen synthesis by transforming growth factor-(beta) in keloid and hypertrophic scar fibroblasts. Ann Plast Surg. 1994;33:148–154. doi:10.1097/00000637-199408000-000057979045
   PubMed Web of Science ®Google Scholar
• Calderon M, Lawrence WT, Banes AJ. Increased proliferation in keloid fibroblasts wounded in vitro. J Surg Res. 1996;61:343–347. doi:10.1006/jsre.1996.01278656606
   PubMed Web of Science ®Google Scholar
• Boyce DE, Ciampolini J, Ruge F, Murison MS, Harding KG. Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg. 2001;54(6):511–516. doi:10.1054/bjps.2000.350911513514
   PubMedGoogle Scholar
• Bernabei P, Rigamonti L, Ariotti S, Stella M, Castagnoli C, Novelli F. Functional analysis of T lymphocytes infiltrating the dermis and epidermis of post-burn hypertrophic scar tissues. Burns. 1999;25(1):43–48. doi:10.1016/S0305-4179(98)00128-410090383
   PubMed Web of Science ®Google Scholar
• Nakaoka H, Miyauchi S, Miki Y. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Derm Venereol. 1995;75(2):102–104.7604635
   PubMed Web of Science ®Google Scholar
• Eraud J, Gonnelli D, Carmassi M, et al. [Differential diagnosis between keloid and hypertrophic scars: a new approach by full-field optical coherence tomography]. Ann Chir Plast Esthet. 2014;59(4):253–260. doi:10.1016/j.anplas.2014.02.00124698338
   PubMed Web of Science ®Google Scholar
• Zurada JM, Kriegel D, Davis IC. Topical treatments for hypertrophic scars. J Am Acad Dermatol. 2006;55:1024–1031. doi:10.1016/j.jaad.2006.03.02117097399
   PubMed Web of Science ®Google Scholar
• Renò F, Grazianetti P, Cannas M. Effects of mechanical compression on hypertrophic scars: prostaglandin E2 release. Burns. 2001;27(3):215–218. doi:10.1016/S0305-4179(00)00101-711311513
   PubMed Web of Science ®Google Scholar
• Chan KY, Lau CL, Adeeb SM, Somasundaram S, Nasir-Zahari M, Randomized A. Placebo-controlled, double-blind, prospective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound. Plast Reconstr Surg. 2005;116(4):1013–1020. doi:10.1097/01.prs.0000178397.05852.ce16163087
   PubMed Web of Science ®Google Scholar
• Richard R, Ward RS. Splinting strategies and controversies. J Burn Care Rehabil. 2005;26(5):392–396. doi:10.1097/01.bcr.0000176886.63559.8b16151283
   PubMedGoogle Scholar
• Ud-Din S, Bowring A, Derbyshire B, Morris J, Bayat A. Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease. Arch Dermatol Res. 2013;305(5):423–432. doi:10.1007/s00403-013-1328-723479004
   PubMed Web of Science ®Google Scholar
• D’Andrea F, Brongo S, Ferraro G, Baroni A. Prevention and treatment of keloids with intralesional verapamil. Dermatology. 2002;204(1):60–62. doi:10.1159/00005181211834852
   PubMed Web of Science ®Google Scholar
• Naeini FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg. 2006;32(8):1023–9; discussion 1029–30.
   Web of Science ®Google Scholar
• Tan KT, Shah N, Pritchard SA, McGrouther DA, Bayat A. The influence of surgical excision margins on keloid prognosis. Ann Plast Surg. 2010;64(1):55–58. doi:10.1097/SAP.0b013e31819b6c3a20010410
   PubMed Web of Science ®Google Scholar
• Cassuto DA, Scrimali L, Siragò P. Treatment of hypertrophic scars and keloids with an LBO laser (532 nm) and silicone gel sheeting. J Cosmet Laser Ther. 2010;12(1):32–37. doi:10.3109/1476417090345384620085452
   PubMed Web of Science ®Google Scholar
• Yun J-S, Choi Y-J, Kim W-S, Lee G-Y. Prevention of thyroidectomy scars in Asian adults using a 532-nm potassium titanyl phosphate laser. Dermatol Surg. 2011;37(12):1747–1753. doi:10.1111/j.1524-4725.2011.02128.x21883646
   PubMed Web of Science ®Google Scholar
• Har-Shai Y, Sabo E, Rohde E, Hyams M, Assaf C, Zouboulis CC. Intralesional cryosurgery enhances the involution of recalcitrant auricular keloids: a new clinical approach supported by experimental studies. Wound Repair Regen. 2006;14(1):18–27. doi:10.1111/wrr.2006.14.issue-116476068
   PubMed Web of Science ®Google Scholar
• Har-Shai Y, Mettanes I, Zilberstein Y, Genin O, Spector I, Pines M. Keloid histopathology after intralesional cryosurgery treatment. J Eur Acad Dermatol Venereol. 2011;25:1027–1036. doi:10.1111/j.1468-3083.2010.03911.x21108665
   PubMed Web of Science ®Google Scholar
• Borok TL, Bray M, Sinclair I, Plafker J, LaBirth L, Rollins C. Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys. 1988;15:865–870. doi:10.1016/0360-3016(88)90119-83182326
   PubMed Web of Science ®Google Scholar
• Furtado F, Hochman B, Ferreira LM. Evaluating keloid recurrence after surgical excision with prospective longitudinal scar assessment scales. J Plast Reconstr Aesthet Surg. 2012;65(7):e175–81. doi:10.1016/j.bjps.2012.02.00522386498
   PubMed Web of Science ®Google Scholar
• Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg. 1996;22(2):126–130. doi:10.1111/j.1524-4725.1996.tb00493.x8608373
   PubMed Web of Science ®Google Scholar
• Bischof M, Krempien R, Debus J, Treiber M. Postoperative electron beam radiotherapy for keloids: objective findings and patient satisfaction in self-assessment. Int J Dermatol. 2007;46(9):971–975. doi:10.1111/ijd.2007.46.issue-917822505
   PubMed Web of Science ®Google Scholar
• Cheraghi N, Cognetta A, Goldberg D. Radiation therapy for the adjunctive treatment of surgically excised keloids: a review. J Clin Aesthet Dermatol. 2017;10(8):12–15.
   PubMedGoogle Scholar
• Doornbos JF, Stoffel TJ, Hass AC, et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys. 1990;18(4):833–839.2108939
   PubMed Web of Science ®Google Scholar
• Kal HB, Veen RE. Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship. Strahlenther Onkol. 2005;181(11):717–723. doi:10.1007/s00066-005-1407-616254707
   PubMed Web of Science ®Google Scholar
• Draaijers LJ, Tempelman FR, Botman YA, et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004;113:1960–1965; discussion 1966–1967.
   Web of Science ®Google Scholar
• Van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the patient and observer scar assessment scale. Plast Reconstr Surg. 2005;116:514–522.16079683
   PubMed Web of Science ®Google Scholar
• Park TH, Seo SW, Kim JK, Chang CH. Outcomes of surgical excision with pressure therapy using magnets and identification of risk factors for recurrent keloids. Plast Reconstr Surg. 2011;128(2):431–439. doi:10.1097/PRS.0b013e31821e700621788835
   PubMed Web of Science ®Google Scholar
• Norris JE. Superficial X-ray therapy in keloid management: a retrospective study of 24 cases and literature review. Plast Reconstr Surg. 1995;95:1051–1055. doi:10.1097/00006534-199505000-000157732115
   PubMed Web of Science ®Google Scholar
• Ollstein RN, Siegel HW, Gillooley JF, Barsa JM. Treatment of keloids by combined surgical excision and immediate postoperative X-ray therapy. Ann Plast Surg. 1981;7:281–285. doi:10.1097/00000637-198110000-000057316418
   PubMedGoogle Scholar
• Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3):E606. doi:10.3390/ijms18030606.28287424
   PubMed Web of Science ®Google Scholar
• Dong X, Mao S, Wen H. Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (Review). Biomed Rep. 2013;1(6):833–836. doi:10.3892/br.2013.16924649037
   PubMedGoogle Scholar
• Ogawa R, Yoshitatsu S, Yoshida K, Miyashita T. Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis. Plast Reconstr Surg. 2009;124(4):1196–1201. doi:10.1097/PRS.0b013e3181b5a3ae19935303
   PubMed Web of Science ®Google Scholar
• Ragoowansi R, Cornes PG, Moss AL, Glees JP. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg. 2003;111(6):1853–1859. doi:10.1097/01.PRS.0000056869.31142.DE12711944
   PubMed Web of Science ®Google Scholar
• Leer JW, van Houtte P, Seegenschmiedt H. Radiotherapy of non-malignant disorders: where do we stand? Radiother Oncol. 2007;83(2):175–177. doi:10.1016/j.radonc.2007.04.00817490769
   PubMed Web of Science ®Google Scholar